Literature DB >> 9762597

Diagnosis of isovaleric acidaemia by tandem mass spectrometry: false positive result due to pivaloylcarnitine in a newborn screening programme.

J E Abdenur1, N A Chamoles, A E Guinle, A B Schenone, A N Fuertes.   

Abstract

Tandem mass spectrometric analysis of acylcarnitines and amino acids has been applied in newborn screening programmes for the detection of several inborn errors of metabolism. We report a false positive result for isovaleric acidaemia in a newborn screening programme using this method. The newborn screening sample showed a very prominent signal corresponding to the mass of isovalerylcarnitine. Repeat samples (age 6 days) of blood and urine showed similar results. However, urine organic acids were normal. Acylcarnitine analysis in blood, breast milk and urine of the mother also showed a prominent signal of the same mass. Gas chromatography-mass spectrometry of the methyl esters demonstrated that the signal in the patient's urine was due to the presence of pivaloylcarnitine, which is isomeric with isovalerylcarnitine. The patient's mother was receiving an antibiotic containing a derivative of pivalic acid to treat a urinary tract infection. Follow-up samples in the patient and the mother confirmed a decrease in the levels of pivaloylcarnitine, concomitant with the discontinuation of the treatment. We conclude that pivaloylcarnitine can give a false positive result for isovaleric acidaemia in newborns whose mothers are on treatment with pivoxilsulbactam-containing antibiotics.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762597     DOI: 10.1023/a:1005424331822

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders.

Authors:  D S Millington; N Terada; D H Chace; Y T Chen; J H Ding; N Kodo; C R Roe
Journal:  Prog Clin Biol Res       Date:  1992

2.  Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate.

Authors:  B Melegh; J Kerner; V Jaszai; L L Bieber
Journal:  Biochem Med Metab Biol       Date:  1990-02

3.  (2-Ethoxyethoxy)acetic acid: an unusual compound found in the gas chromatographic analysis of urinary organic acids.

Authors:  J P Kamerling; M Duran; L Bruinvis; D Ketting; S K Wadman; C J de Groot; F A Hommes
Journal:  Clin Chim Acta       Date:  1977-06-15       Impact factor: 3.786

Review 4.  New developments in neonatal screening.

Authors:  K Bartlett; S J Eaton; M Pourfarzam
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

5.  Newborn screening by tandem mass spectrometry (MS-MS)

Authors:  L Sweetman
Journal:  Clin Chem       Date:  1996-03       Impact factor: 8.327

6.  Transient reduction of human left ventricular mass in carnitine depletion induced by antibiotics containing pivalic acid.

Authors:  K Abrahamsson; M Mellander; B O Eriksson; E Holme; U Jodal; A Jönsson; S Lindstedt
Journal:  Br Heart J       Date:  1995-12

7.  Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency.

Authors:  T L Broderick; S C Christos; B A Wolf; D DiDomenico; A L Shug; D J Paulson
Journal:  Metabolism       Date:  1995-04       Impact factor: 8.694

8.  Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies.

Authors:  R Ziadeh; E P Hoffman; D N Finegold; R C Hoop; J C Brackett; A W Strauss; E W Naylor
Journal:  Pediatr Res       Date:  1995-05       Impact factor: 3.756

9.  Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.

Authors:  M S Rashed; P T Ozand; M J Bennett; J J Barnard; D R Govindaraju; P Rinaldo
Journal:  Clin Chem       Date:  1995-08       Impact factor: 8.327

10.  Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry.

Authors:  M S Rashed; P T Ozand; M P Bucknall; D Little
Journal:  Pediatr Res       Date:  1995-09       Impact factor: 3.756

  10 in total
  15 in total

1.  Introduction of a Simple Second Tier Screening Test for C5 Isobars in Dried Blood Spots: Reducing the False Positive Rate for Isovaleric Acidaemia in Expanded Newborn Screening.

Authors:  R S Carling; D Burden; I Hutton; R Randle; K John; J R Bonham
Journal:  JIMD Rep       Date:  2017-06-20

2.  International cooperation in the expansion of a newborn screening programme in Lebanon: a possible model for other programmes.

Authors:  I Khneisser; S M Adib; A Megarbane; Z Lukacs
Journal:  J Inherit Metab Dis       Date:  2008-11-21       Impact factor: 4.982

3.  Application of a second-tier newborn screening assay for c5 isoforms.

Authors:  T Cloppenborg; N Janzen; Hj Wagner; U Steuerwald; M Peter; Am Das
Journal:  JIMD Rep       Date:  2013-11-06

4.  Mass Spectral Library of Acylcarnitines Derived from Human Urine.

Authors:  Xinjian Yan; Sanford P Markey; Ramesh Marupaka; Qian Dong; Brian T Cooper; Yuri A Mirokhin; William E Wallace; Stephen E Stein
Journal:  Anal Chem       Date:  2020-04-23       Impact factor: 6.986

Review 5.  Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity.

Authors:  Jerry Vockley; Regina Ensenauer
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

6.  A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening.

Authors:  Regina Ensenauer; Jerry Vockley; Jan-Marie Willard; Joseph C Huey; Jörn Oliver Sass; Steven D Edland; Barbara K Burton; Susan A Berry; René Santer; Sarah Grünert; Hans-Georg Koch; Iris Marquardt; Piero Rinaldo; Sihoun Hahn; Dietrich Matern
Journal:  Am J Hum Genet       Date:  2004-10-14       Impact factor: 11.025

7.  An LC-MS/MS method to quantify acylcarnitine species including isomeric and odd-numbered forms in plasma and tissues.

Authors:  Pieter Giesbertz; Josef Ecker; Alexander Haag; Britta Spanier; Hannelore Daniel
Journal:  J Lipid Res       Date:  2015-08-03       Impact factor: 5.922

8.  Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007).

Authors:  D Matern; S Tortorelli; D Oglesbee; D Gavrilov; P Rinaldo
Journal:  J Inherit Metab Dis       Date:  2007-07-23       Impact factor: 4.982

9.  Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".

Authors:  Paul E Minkler; Maria S K Stoll; Stephen T Ingalls; Janos Kerner; Charles L Hoppel
Journal:  Mol Genet Metab       Date:  2015-10-08       Impact factor: 4.797

Review 10.  Pharmacokinetics of L-carnitine.

Authors:  Allan M Evans; Gianfranco Fornasini
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.